| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab175702-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $79.90 | |
| Ab175702-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $389.90 | |
| Ab175702-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $889.90 | |
| Ab175702-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,429.90 |
Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1-EM; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Vonlerolizumab (anti-OX40) - Primary antibody, specific to TNFRSF4 |
|---|---|
| Synonyms | ACT 35 antibody | ACT35 antibody | ACT35 antigen antibody | ATC35 antigen antibody | CD 134 antibody | CD134 antibody | CD134 antigen antibody | IMD16 antibody | Lymphoid activation antigene ACT35 antibody | OX 40 antibody | OX40 antibody | OX40 antigen a |
| Specifications & Purity | RUO, Moligand™, ≥95%(SDS-PAGE&SEC), See COA |
| Host species | Human |
| Specificity | TNFRSF4 |
| Conjugation | Unconjugated |
| Grade | Moligand™, RUO |
| Action Type | ANTIBODY |
| Mechanism of action | Antibody of OX40 |
| Product Description | Vonlerolizumab (anti-OX40) is a humanized IgG agonistic monoclonal OX40-specific antibody. Vonlerolizumab (anti-OX40) can be used for the research of cancer. |
| Isotype | Human IgG1-EM |
|---|---|
| Light Chain Type | kappa |
| Purification Method | Protein A purified |
| Form | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
| CAS | 1638935-72-4 |
Vonlerolizumab (anti-OX40) (Ab175702) - Flow Cytometry
OX40-NF-κB-Jurkat cells at 1×105 cell/well can bind Vonlerolizumab (anti-OX40) (Ab175702) , with the EC
₅₀
is 0.03 μg/mL.
Vonlerolizumab (anti-OX40) (Ab175702) - SEC
The purity of Vonlerolizumab (anti-OX40) (Ab175702) is more than 95% verified by HPLC.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| IMGT/mAb-DB | 608 |
|---|
Enter Lot Number to search for COA:
